BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 19258378)

  • 1. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shoulder acute pain in primary healthcare: is retraining effective for GP principals? SAPPHIRE--a randomized controlled trial.
    Watson J; Helliwell P; Morton V; Adebajo A; Dickson J; Russell I; Torgerson D
    Rheumatology (Oxford); 2008 Dec; 47(12):1795-802. PubMed ID: 18820310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost consequences analysis of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care.
    James M; Stokes EA; Thomas E; Dziedzic K; Hay EM
    Rheumatology (Oxford); 2005 Nov; 44(11):1447-51. PubMed ID: 16091398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of two physiotherapy interventions for primary care back and neck pain patients: cost effectiveness analysis.
    Manca A; Dumville JC; Torgerson DJ; Klaber Moffett JA; Mooney MP; Jackson DA; Eaton S
    Rheumatology (Oxford); 2007 Sep; 46(9):1495-501. PubMed ID: 17711873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a chest pain observation unit likely to be cost effective at my hospital? Extrapolation of data from a randomised controlled trial.
    Goodacre S; Dixon S
    Emerg Med J; 2005 Jun; 22(6):418-22. PubMed ID: 15911949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
    Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
    Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel disease.
    Richardson G; Sculpher M; Kennedy A; Nelson E; Reeves D; Roberts C; Robinson A; Rogers A; Thompson D
    J Health Serv Res Policy; 2006 Oct; 11(4):225-30. PubMed ID: 17018196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation of three physiotherapy treatments for non-specific neck disorders alongside a randomized trial.
    Lewis M; James M; Stokes E; Hill J; Sim J; Hay E; Dziedzic K
    Rheumatology (Oxford); 2007 Nov; 46(11):1701-8. PubMed ID: 17956916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.
    Williams NH; Edwards RT; Linck P; Muntz R; Hibbs R; Wilkinson C; Russell I; Russell D; Hounsome B
    Fam Pract; 2004 Dec; 21(6):643-50. PubMed ID: 15531626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of open colposuspension versus laparoscopic colposuspension in the treatment of urodynamic stress incontinence.
    Dumville JC; Manca A; Kitchener HC; Smith AR; Nelson L; Torgerson DJ;
    BJOG; 2006 Sep; 113(9):1014-22. PubMed ID: 16956333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falls and health status in elderly women following first eye cataract surgery: an economic evaluation conducted alongside a randomised controlled trial.
    Sach TH; Foss AJ; Gregson RM; Zaman A; Osborn F; Masud T; Harwood RH
    Br J Ophthalmol; 2007 Dec; 91(12):1675-9. PubMed ID: 17585002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.
    Durand-Zaleski I; Earlam S; Fordy C; Davies M; Allen-Mersh TG
    Cancer; 1998 Sep; 83(5):882-8. PubMed ID: 9731890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
    Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
    Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care.
    Wonderling D; Vickers AJ; Grieve R; McCarney R
    BMJ; 2004 Mar; 328(7442):747. PubMed ID: 15023830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data.
    Briggs AH; Lozano-Ortega G; Spencer S; Bale G; Spencer MD; Burge PS
    Value Health; 2006; 9(4):227-35. PubMed ID: 16903992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial.
    Whitehurst DG; Lewis M; Yao GL; Bryan S; Raftery JP; Mullis R; Hay EM
    Arthritis Rheum; 2007 Apr; 57(3):466-73. PubMed ID: 17394176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care.
    UK BEAM Trial Team
    BMJ; 2004 Dec; 329(7479):1381. PubMed ID: 15556954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.
    McInnes G; Burke TA; Carides G
    J Hum Hypertens; 2006 Jan; 20(1):51-8. PubMed ID: 16357874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.